Radioligand, Therapies

Radioligand Therapies Market Set for Significant Growth by 2034, Driven by Rising Cancer Burden and Targeted Radiopharmaceutical Innovation | DelveInsight

Veröffentlicht: 17.03.2026 um 18:11 Uhr, prnewswire.co.uk

DelveInsight Business Research, LLP United States of America United Kingdom


+14699457679

Logo: https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg 

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/radioligand-therapies-market-set-for-significant-growth-by-2034-driven-by-rising-cancer-burden-and-targeted-radiopharmaceutical-innovation--delveinsight-302711917.html

en | boerse | 68720149 |